| Income Statement |
| Total Revenue | 619.80M |
|
| Revenues (USD) | 619.80M |
| Cost of Revenue | 356.00M |
| Gross Profit | 263.80M |
| Operating Expenses | 295.60M |
| Research and Development Expense | 44.90M |
| Selling, General and Administrative Expense | 199.30M |
| Operating Income | -31.80M |
| Interest Expense | 51.10M |
| Income Tax Expense | 12.30M |
| Net Income | -91.80M |
| Net Income Common Stock | -91.80M |
| Net Income Common Stock (USD) | -91.80M |
| Consolidated Income | -91.80M |
| Earnings per Basic Share | -1.35 |
| Earnings per Basic Share (USD) | -1.35 |
| Earnings per Diluted Share | -1.35 |
| Earning Before Interest & Taxes (EBIT) | -28.40M |
| Earning Before Interest & Taxes (USD) | -28.40M |
| Weighted Average Shares | 68.20M |
| Weighted Average Shares Diluted | 68.20M |
| Balance Sheet |
| Cash and Equivalents | 140.40M |
| Cash and Equivalents (USD) | 140.40M |
| Trade and Non-Trade Receivables | 359.90M |
| Current Assets | 1.38B |
| Property, Plant & Equipment Net | 1.50B |
| Total Assets | 5.63B |
| Debt Current | 228.20M |
| Total Debt | 2.84B |
| Current Liabilities | 962.40M |
| Debt Non-Current | 2.62B |
| Total Liabilities | 3.78B |
| Accumulated Retained Earnings (Deficit) | -1.09B |
| Accumulated Other Comprehensive Income | -4.10M |
| Shareholders Equity | 1.85B |
| Shareholders Equity (USD) | 1.85B |
| Assets Non-Current | 4.25B |
| Total Debt (USD) | 2.84B |
| Goodwill and Intangible Assets | 2.52B |
| Inventory | 611.50M |
| Liabilities Non-Current | 2.81B |
| Trade and Non-Trade Payables | 243.50M |
| Tax Liabilities | 100.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 112.90M |
| Net Cash Flow from Financing | 37.60M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -29.40M |
| Capital Expenditure | -34.00M |
| Issuance (Purchase) of Equity Shares | 1.80M |
| Issuance (Repayment) of Debt Securities | 36.90M |
| Net Cash Flow from Investing | -34.00M |
| Net Cash Flow from Operations | -33.00M |
| Share Based Compensation | 10.70M |